120
Views
30
CrossRef citations to date
0
Altmetric
Original Research

Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A

, , , , , , & show all
Pages 985-991 | Published online: 10 May 2011

References

  • HaussDJOral lipid-based formulationsAdv Drug Deliv Rev200759766767617618704
  • PiaoHKamiyaNWatanabeJOral delivery of diclofenac sodium using a novel solid-in-oil suspensionInt J Pharm20063131–215916216530362
  • WuWWangYQueLEnhanced bioavailability of silymarin by self-microemulsifying drug delivery systemEur J Pharm Biopharm200663328829416527467
  • StrickleyRGSolubilizing excipients in oral and injectable formulationsPharm Res200421220123015032302
  • PorterCJTrevaskisNLCharmanWNLipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov20076323124817330072
  • KhooSMShacklefordDMPorterCJEdwardsGACharmanWNIntestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogsPharm Res20032091460146514567642
  • ChengMBWangJCLiYHCharacterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzymeJ Control Release20081291414818474405
  • PrasadYVPuthliSPEaimtrakarnSEnhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in ratsInt J Pharm2003250118119012480284
  • ConstantinidesPPLipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspectsPharm Res19951211156115728592652
  • LiuYNZhouZMChenPEvidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore openingClin Exp Pharmacol Physiol200835221121617941891
  • ZhuHWangZMaCNeuroprotective effects of hydroxysafflor yellow A: In vivo and in vitro studiesPlanta Med200369542943312802724
  • ZhuHBWangZHTianJWFuFHLiuKLiCLProtective effect of hydroxy safflor yellow A on experimental cerebral ischemia in ratsYao Xue Xue Bao2005401211441146 Chinese.16496682
  • WangSSunMPingQEnhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in ratsInt J Pharm20083581–219820418417306
  • QiJSunMPingQThe mechanisms for enhanced oral absorption of hydroxysafflor yellow A by Chuanxiong volatile oilPlanta Med201076878679220033864
  • AboofazeliRLawrenceMJInvestigations into the formation and characterization of phospholipid microemulsions. I Pseudoternary phase diagrams of systems containing water-lecithin-alcohol-isopropyl myristateInt J Pharm1993931–3161175
  • TavakoliSHajrasoulihaARJabehdar-MaralaniPModulated hemodynamic response to clonidine in bile duct-ligated rats: The role of nitric oxideEur J Pharmacol20065421–314815316824510
  • ZangenbergNHMullertzAKristensenHGHovgaardLA dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calciumEur J Pharm Sci200114211512211500257
  • ZangenbergNHMullertzAKristensenHGHovgaardLA dynamic in vitro lipolysis model. II: Evaluation of the modelEur J Pharm Sci200114323724411576829
  • FatourosDGBergenstahlBMullertzAMorphological observations on a lipid-based drug delivery system during in vitro digestionEur J Pharm Sci2007312859417418543
  • WilsonTHWisemanGThe use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surfaceJ Physiol195412311162513131249
  • CornaireGWoodleyJHermannPCloarecAArellanoCHouinGImpact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivoInt J Pharm2004278111913115158955
  • QiJJinXHuangLPingQSimultaneous determination of hydroxysafflor yellow A and ferulic acid in rat plasma after oral administration of the co-extractum of Rhizoma chuanxiong and Flos Carthami by HPLC-diode array detectorBiomed Chromatogr200721881682217441216
  • FormarizTPChiavacciLASarmentoVHStructural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin releaseColloids Surf B Biointerfaces200863228729518313903
  • YangSCBenitaSEnhanced absorption and drug targeting by positively charged submicron emulsionsDrug Develop Res201050476486
  • AlanyRGRadesTAgatonovic-KustrinSDaviesNMTuckerIGEffects of alcohols and diols on the phase behaviour of quaternary systemsInt J Pharm2000196214114510699705
  • KawakamiKYoshikawaTHayashiTNishiharaYMasudaKMicroemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo studyJ Control Release2002811–2758211992680
  • ShaXYanGWuYLiJFangXEffect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cellsEur J Pharm Sci200524547748615784337
  • YehPYSmithPLEllensHEffect of medium-chain glycerides on physiological properties of rabbit intestinal epithelium in vitroPharm Res1994118114811547971716
  • ShiauYFKelemenRJReedMAAcidic mucin layer facilitates micelle dissociation and fatty acid diffusionAm J Physiol19902594 Pt 1G671G6752221076
  • ThomsonABSchoellerCKeelanMSmithLClandininMTLipid absorption: Passing through the unstirred layers, brush-border membrane, and beyondCan J Physiol Pharmacol19937185315558306192
  • DahanAHoffmanAThe effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in ratsEur J Pharm Biopharm20076719610517329087
  • KimuraYHosodaYShimaMAdachiSMatsunoRPhysicochemical properties of fatty acids for assessing the threshold concentration to enhance the absorption of a hydrophilic substanceBiosci Biotechnol Biochem1998623443447
  • AungstBJIntestinal permeation enhancersJ Pharm Sci200089442944210737905